期刊文献+

不同病情程度下类风湿关节炎患者自我管理能力比较 被引量:5

Comparison of Self-management Ability of Patients with Rheumatoid Arthritis in Different Degrees
下载PDF
导出
摘要 目的:比较不同病情程度下类风湿关节炎患者自我管理能力。方法:选取2014年6月至2015年6月我院收治的类风湿关节炎患者80例,依据病情程度分为重度组、中度组、轻度组,比较三组患者的自我管理知识评分、能力评分及达标率。结果:重度组、中度组、轻度组患者的自我管理知识评分、能力评分均依次升高,达标率分别为54.17%、64.29%、78.57%,以上差异均具有统计学意义(P<0.05)。结论:类风湿关节炎病情越严重患者自我管理能力越低,医护人员应加强健康教育,提高患者自我管理能力。 Objective: To compare the self-management ability of patients with rheumatoid arthritis under different conditions. Method: 80 cases with rheumatoid arthritis in our hospital from June 2014 to June2015 were selected and divided into three groups: severe group,moderate group and mild group according to the severity of disease. The comparsisons were made about the standard rate,knowledge scores and ability scores of self-management between the three groups. Result: In the severe group,moderate group and mild group,there was a significant increase in the standard nates scores,knowledge scores and ability scores of self-management,and the standard rates the three groups were 54. 17%,64. 29%,78. 57% respectively,the differences were statistically significant( P〈0. 05). Conclusion: The graver condition of rheumatord arthritis is the lower self-management ability of the patients. Therefore,health education should be strengthened to improve the ability of self-management of the patients.
作者 崔若玫
出处 《河北医学》 CAS 2016年第3期358-361,共4页 Hebei Medicine
基金 云南省卫生科技计划项目 (编号:2014NS172)
关键词 类风湿关节炎 自我管理 病情 Rheumatoid arthritis Self-management Disease
  • 相关文献

参考文献7

二级参考文献45

  • 1魏勇,张有建.中西医结合治疗类风湿性关节炎118例[J].河南中医,2004,24(5):49-50. 被引量:14
  • 2黄仰模,赵威.中医药治疗类风湿关节炎的生存质量研究新进展[J].中医药学刊,2005,23(10):1749-1750. 被引量:4
  • 3张俊,邵俊杰,蒋垚,曾炳芳.全膝关节置换术后持续性冷冻压迫法疗效分析[J].国际骨科学杂志,2007,28(4):264-267. 被引量:18
  • 4Borstlap M,Laar M,Zant J ,et al. Components of health : an analysisin rheumatoid arthritis using quality of life questionnaires and clini-cal and laboratory variables [ J ]. Ann Rheum Dis, 1993,52 (6):654 -650.
  • 5Zeng QY, Chen R, Darmawan J, et al. Rheumatic diseases inChina. Arthritis Res Ther,2008, 10:17-27.
  • 6Firestein GS. Evolving concepts of rheumatoid arthritis. Nature,2003,423;356-361.
  • 7Smolen JS, Landew6 R, Breedveld FC, et al. EULARrecommendations for the management of rheumatoid arthritis withsynthetic and biological disease-modifying antirheumatic drugs.Ann Rheum Dis, 2010,69:964-975.
  • 8Bathon JM, Martin RW, Fleischmann RM, et al. A comparison ofetanercept and methotrexate in patients with early rheumatoidarthritis. N Engl J Med, 2000,343:1586-1593.
  • 9Smolen JS, van der Heijde DM,St Clair EW, et al. Predictors ofjoint damage in patients with early rheumatoid arthritis treated withhigh-dose methotrexate with or without concomitant infliximab :results from the ASPIRE trial. Arthritis Rheum, 2006,54:702-710.
  • 10National Institute for Health and Clinical Excellence. Guide to themethods of technology appraisal. London : National Institute forHealth and Clinical Excellence, 2008;45-46.

共引文献73

同被引文献73

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部